Electroclinical aspects and therapy of Han patients with juvenile myoclonic epilepsy in northern China

被引:1
|
作者
Wang, Le [1 ]
Jiang, Zhao [1 ]
Chen, Bei-Bei [1 ]
Wang, Cheng-Tai [2 ]
Wang, Jin-Xiang [1 ]
Bai, Jie [1 ]
Wang, Bi [1 ]
Jin, Lang [1 ]
Zhang, Wen Juan [1 ]
Deng, Yan-Chun [1 ]
Zhao, Gang [1 ]
Dang, Jing-Xia [3 ]
Wang, Dong [4 ]
Jia, Shan-Shan [4 ]
Wang, Tian-Cheng [5 ]
Jia, Fei-Yong [6 ]
Zhang, Li [7 ]
Liu, Yong-Hong [1 ]
机构
[1] Fourth Mil Med Univ, Xijing Hosp, Dept Neurol, 127 West ChangLe Rd, Xian 710032, Peoples R China
[2] Baoji Tradit Chinese Med Hosp, Dept Neurol, Baoji, Peoples R China
[3] Xi An Jiao Tong Univ, Dept Neurol, Affiliated Hosp 1, Xian, Peoples R China
[4] Xi An Jiao Tong Univ, Xian Pediat Hosp, Dept Neurol, Xian, Peoples R China
[5] Lanzhou Univ, Hosp 2, Dept Neurol, Lanzhou, Peoples R China
[6] Jilin Univ, Hosp 1, Dept Pediat Neurol & Neurorehabil, Changchun, Peoples R China
[7] Xian Gaoxin Hosp, Dept Neurol, Xian, Peoples R China
基金
中国国家自然科学基金;
关键词
Electroclinical characteristics; Photoparoxysmal responses; Generalized spike-wave discharge; Valproate; VALPROIC ACID; OPEN-LABEL; TOPIRAMATE; EFFICACY; LEVETIRACETAM; EXACERBATION; EPIDEMIOLOGY; LAMOTRIGINE; JME;
D O I
10.1016/j.yebeh.2016.07.011
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Objective: The objective of this study was to assess the electroclinical aspects and treatment of Han patients with juvenile myoclonic epilepsy (JME) in northern China. Methods: One hundred fifty-six outpatients with JME from six epilepsy centers, between January 2011 and June 2012, were followed up for at least two years. They underwent twenty-four-hour video-EEG recording. Brain imaging was performed using magnetic resonance imaging (MRI). Clinical aspects, electroencephalographic (EEG) features, and antiepileptic drugs (AEDs) received were reviewed. Results: Generalized tonic-clonic seizures (GTCS) were found in 150/156 patients. Delay of diagnosis was 4.60 +/- 9.92 years. Photosensitivity was more common in eye closure condition during IPS in patients with JME; in addition, patients with JME with myoclonic seizures (MS) and GTCS as seizure types were likely to present photoparoxysmal responses (PPRs). The 82 nontreated patients showed a median latency to first interictal or ictal generalized spike-wave discharge (GSWD) of 50 min (IQR: 22-102 min). The first GSWDs were recorded in 63%, 76%, 90%, and 98% patients within one, two, three, and 4 h, respectively; only 2% of patients had first GSWDs after 4 h. One hundred eleven patients (111/156) chose extended-release valproate (VPA) at daily doses <= 1000 mg. The percentages of seizure-free patients among MS, GTCS, and absence seizure (AS) groups were 88.3%, 99.0%, and 94.9%, respectively. Conclusion: Photoparoxysmal responses were more common in patients with JME with MS and GTCS and rare in patients with JME with MS and AS in northern Chinese Han patients. Most patients with JME in northern China chose VPA as first therapeutic choice, and low dose (500 to 1000 mg daily) of extended-release VPA may be an optimal choice for them. Video-EEG monitoring for at least 4 h may be helpful in detecting the first interictal or ictal GSWD in patients with potential JME. Moreover, video-EEG monitoring performed at about 9 o'clock in the morning with patients in the awake state might be useful to find the first GSWD. For JME diagnosis, Class II criteria are more helpful than Class I counterparts, the latter yielding more missed diagnoses. (C) 2016 Elsevier Inc. All rights reserved.
引用
收藏
页码:204 / 208
页数:5
相关论文
共 40 条
  • [11] Treatment and challenges with antiepileptic drugs in patients with juvenile myoclonic epilepsy
    Landmark, Cecilie Johannessen
    Flogstad, Ida
    Syvertsen, Marte
    Baftiu, Arton
    Enger, Ulla
    Koht, Jeanette
    Johannessen, Svein, I
    EPILEPSY & BEHAVIOR, 2019, 98 : 110 - 116
  • [12] Pharmacokinetics of valproic acid in patients with juvenile myoclonic epilepsy on monotherapy
    Sundqvist, A
    Tomson, T
    Lundkvist, B
    THERAPEUTIC DRUG MONITORING, 1997, 19 (02) : 153 - 159
  • [13] Topiramate or valproate in patients with juvenile myoclonic epilepsy: A randomized open-label comparison
    Levisohn, Paul M.
    Holland, Katherine D.
    EPILEPSY & BEHAVIOR, 2007, 10 (04) : 547 - 552
  • [14] Analysis of Clinical Characteristics, Background, and Paroxysmal Activity in EEG of Patients with Juvenile Myoclonic Epilepsy
    Santiago-Rodriguez, Efrain
    Zaldivar-Uribe, Elba
    BRAIN SCIENCES, 2022, 12 (01)
  • [15] A Randomized Open-Label Comparison of Lamotrigine and Valproate in Patients with Juvenile Myoclonic Epilepsy
    Nejad, S. E. M.
    Nikpour, M. R. A.
    Rahim, F.
    Naghibi, S. N.
    Bahrammi, M. A.
    INTERNATIONAL JOURNAL OF PHARMACOLOGY, 2009, 5 (05) : 313 - 318
  • [16] Usefulness of a morning routine EEG recording in patients with juvenile myoclonic epilepsy
    Labate, Angelo
    Ambrosio, Roberta
    Gambardella, Antonio
    Sturniolo, Miriam
    Pucci, Franco
    Quattrone, Aldo
    EPILEPSY RESEARCH, 2007, 77 (01) : 17 - 21
  • [17] Epileptic discharges and phasic sleep phenomena in patients with juvenile myoclonic epilepsy
    Bonakis, Anastasios
    Koutroumanidis, Michalis
    EPILEPSIA, 2009, 50 (11) : 2434 - 2445
  • [18] The association between temperament features and childhood traumas in patients with juvenile myoclonic epilepsy
    Yasar, Alisan Burak
    Sayman, Ceyhun
    Erdogan Taycan, Serap
    Cetinkaya, Yilmaz
    Gunduz, Anil
    Tireli, Hulya
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2020, 50 (05) : 1314 - 1322
  • [19] Levetiracetam May Worsen Myoclonus in Patients With Juvenile Myoclonic Epilepsy: Case Reports
    Babtain, Fawzi A.
    CLINICAL NEUROPHARMACOLOGY, 2012, 35 (04) : 201 - 202
  • [20] Lamotrigine for patients with juvenile myoclonic epilepsy following prior treatment with valproate: results of an open-label study
    Morris, GL
    Hammer, AE
    Kustra, RP
    Messenheimer, JA
    EPILEPSY & BEHAVIOR, 2004, 5 (04) : 509 - 512